InVivo Therapeutics Corporation Announces Business Updates

Published: Sep 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today announced several business updates. The highlights are being provided in connection with the Company’s presentation today at the 14th Annual Rodman and Renshaw Healthcare Conference at the Waldorf Astoria in New York City.

Back to news